Fortbildung bei der DGRA e.V.
DGRA-Workshop
Workshop on drug policy, new pharmaceutical procedures in EC
18. - 19. April 2007 in Sofia
Moderation
Termine
Mittwoch, 18. April 2007 | 08.45 Uhr bis 17.30 Uhr
Donnerstag, 19. April 2007 | 09.00 Uhr bis 15.00 Uhr Termin in den eigenen Kalender übertragen
Veranstaltungsort
Medical University Sofia, Bulgarien
Blvd Acad. Ivan Geshov 15, 1431 Sofia
Tel.: (02) 9531 174
Routenplaner
Download
-
Programmvorschau Änderungen vorbehalten
Programm am 18. April 2007
8.45 Opening 9.00 New European pharmaceutical Legislation in 2005 General Principles - Major changes in the pharmaceutical legislation in 2005: - The New Decentralised Procedure – global marketing authorization
- Introduction of the Europe an reference drug product
- Implementation of the decree “Sunset”
- Procedures for transparency
9.45 Experience in the implementation of the new European pharmaceutical legislation - in data exclusivity and transparency rules
B. Sträter, Attorney at Law10.15 Advantages and challenges in the pharmaceutical legislation 2005 for generics Dr. T. Benisheva, Faculty of Public Health 10.45 Coffee Break 11.15 EU Marketing Authorisation (MRP+DP+CMD/h/) Industry regulatory perspectives - Challenges for generics in the new European environment
Dr. Th. Faust, Hexal AG12.00 Presentation and discussion of the Guideline “Potential risk to public health” concerning medicines
Dr. B. Lehmann, BfArMDiscussion 13.00 Lunch 14.00 CMD(h) Procedures and challenges – one year experience Dr. P. Bachmann, BfArM 14.45 An industry perspective/Challenges for the implementation of the pharmaceutical Review 2005 in Bulgaria
Dr. A. Mladenov, Bulgarian pharmaceutical industry15.10 Ten years European regulatory frame for changing the classification of the medical product (OTC-Switch) for human use (analysis and Member State examples)
Dr. I. Getov, Dr. G. Petrova, Faculty of Pharmacy15.30 Coffee Break 16.00 Pharmacovigilance European Legislation - Changes in the Pharmacovigilance system in the Review 2005 17.30 New Pharmacovigilance obligations in the authorisation procedures: - The Pharmacovigilance System
- The Risk Management System (ICH E2E)
Programm am 19. April 2007
9.00 Clinical Trials Paediatric Medicines – the European regulatory framework, objective for the Regulation, Committee for clinical trials
- The new Pediatric Regulation - Establishment and Role of the Pediatric Committee
Dr. D. Brasseur, Belgium
10.30 Coffee Break 11.00 Paediatric Medicines – the European regulatory frame, objective for the Regulation - System of Incentives for paediatric research
- Extension of Supplementary Protection Certificate, Data exclusivity for Paediatrics Marketing Authorization – PUMA
- Consequences for drug development
12.00 Lunch Breack 13.00 Directive for clinical trials - The EU Clinical Trial Directive – legal background Dr. B. Lehmann, BfArM 13.30 The authorization procedure for clinical trials – implementation in Germany Dr. H. Krafft, PEI 14.30 Panel Discussion - Changes in the EU Pharmaceutical Legislation – chances and challenges for the Pharmaceutical Industry in Bulgaria
15.00 Closing Remarks -
Kostenbeitrag und Stornierungen
Cost contribution: € 60,-
-
Anreise und Unterkunft
Hotel Rila
(Preis EZ: 50 - 60 E)
Tel: +359/2/93 79 130
Fax: +359/2/980 48 13
e-mail: rila@mbox.contact.bg
http://www.online.bg/rila/index-en.htm
Hotel Central (4 Sterne)
(Preis EZ : 70 - 90 €)
Sofia 1000
52 Hristo Botev
Tel: +359/2/981 23 64
Fax: +359/2/986 45 61
e-mail cental@central-hotel.com
www.central-hotel.com
Central Hotel Forum (4 Sterne)
(Preis EZ : 70 - 90 €)
Sofia 1612
41 Tzar Boris III Blvd
Tel: +359/2/954 44 44
Fax: +359/2/954 33 33
e-mail cental@central-hotel.com
www.central-hotel.com
Hotel Anel (5 Sterne)
(Preis EZ: 90 - 110 €)
14 Todor Alexandrov Blvd.
Tel: +359/2/911 99 00
Fax: +359/2/911 97 61
hotelanel@hotelanel.com
www.hotelanel.com -
Unterlagen Mitgliedern vorbehalten